Fennec Pharmaceuticals Inc (NAS:FENC)
$ 4.49 0.26 (6.15%) Market Cap: 123.50 Mil Enterprise Value: 104.67 Mil PE Ratio: 112.25 PB Ratio: 0 GF Score: 27/100

Q2 2023 Fennec Pharmaceuticals Inc Earnings Call Transcript

Aug 03, 2023 / 12:30PM GMT
Release Date Price: $8.01 (-7.29%)
Operator

Good morning, ladies and gentlemen, and welcome to the Fennec Pharmaceuticals second-quarter 2023 earnings and corporate update conference call. (Operator Instructions) As a reminder, today's conference call is being recorded.

Now, I would like to turn the conference over to Fennec's Chief Financial Officer, Robert Andrade.

Robert Andrade
Fennec Pharmaceuticals Inc. - CFO

Thank you, operator, and good morning, everyone. We are delighted that you can join us today for Fennec Pharmaceuticals' second-quarter 2023 earnings conference call, during which we will review our financial results as well as provide a general business update. Joining me from Fennec this morning is Rosty Raykov, our Chief Executive Officer; and our newly appointed Chief Operating Officer, Adrian Haigh.

Before we begin, I would like to remind you that during this call, the company will be making forward-looking statements that are subject to risks and uncertainties that may cause actual results to differ from the results discussed in the forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot